SCHEMBL6977062

SCHEMBL6977062

CN(c1ccc(F)cc1)S(=O)(=O)c1ccc(CBr)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.57
▸ MAPT P10636 3/20 0.53
▸ MCOLN3 Q8TDD5 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.49
▸ CNR2 P34972 5/20 0.46
▸ CNR1 P21554 4/20 0.46
▸ CA12 O43570 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ PTGDR2 Q9Y5Y4 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ PSEN1 P49768 1/20 0.42
▸ PSEN2 P49810 1/20 0.42
▸ APH1B Q8WW43 1/20 0.42
▸ NCSTN Q92542 1/20 0.42
▸ APH1A Q96BI3 1/20 0.42
▸ PSENEN Q9NZ42 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982565 1.00 FFAR1 (0.57) FFAR1MAPTMCOLN3NPSR1CNR2
SCHEMBL6968508 0.84 FFAR1 (0.57) FFAR1MAPTMCOLN3NPSR1CNR2
SCHEMBL15374351 0.82 FFAR1 (0.61) FFAR1MAPTMCOLN3NPSR1CA12
SCHEMBL6828487 0.80 MAPT (0.82) FFAR1MAPTMCOLN3NPSR1CNR2
SCHEMBL9201669 0.79 FFAR1 (0.61) FFAR1MAPTMCOLN3NPSR1CA12
SCHEMBL12070564 0.79 FFAR1 (0.61) FFAR1MAPTMCOLN3NPSR1CA12
SCHEMBL14469933 0.78 FFAR1 (0.74) FFAR1MAPTMCOLN3NPSR1CA12
SCHEMBL10186890 0.78 FFAR1 (0.74) FFAR1MAPTMCOLN3NPSR1CA12
SCHEMBL9586608 0.76 HTR2A (0.51) CA12CA9KMT2A
SCHEMBL3069358 0.76 LMNA (0.53) MAPTTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 — — EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 — — US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 — — EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 — — EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 — — WO disclosed
Send feedback